ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Colorectal Cancer Screening Programs Could Cut Future Treatment Costs

September 25, 2009

Senate Bill Would Require Clinical Trials To Test Gender, Racial Differences In Therapies

August 10, 1990

NCI Funds; Ad Hoc Group Approves NCCTG Renewal

September 18, 1981

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010

Reauthorization Bill Ready For Senate Floor; Report to Panel Makes Clear Why Renewal Needed

April 22, 1988